Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Authors: Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman et al.

Year: 2020

ReactogenicityImmunogenicityMedicineTolerabilityVirology